Over 1000 Orphan Drugs in Clinical Trials in the US - Eylea, Actimmune, Ravicti Among Key Approved Therapies
August 07, 2023 06:43 ET
|
Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...
QSAM Biosciences Receives Second Key Patent in Europe for its Clinical Stage Radiopharmaceutical Drug Candidate, CycloSam®
April 26, 2023 08:00 ET
|
QSAM Biosciences Inc.
Austin, TX, April 26, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...
Global Compound Management Market Size To Reach $897.1 Billion at a CAGR of 16.5% | Vantage Market Research
February 28, 2023 10:24 ET
|
Vantage Market Research
WASHINGTON, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The Global Compound Management Market is valued at USD 355.5 Billion in 2021 and is projected to reach a value of USD 897.1 Billion by 2028 at a CAGR...
Outlook on the Monkeypox Treatment Global Market to 2035 - Focus on Therapeutics, Vaccines and Diagnostic Kits
January 31, 2023 10:38 ET
|
Research and Markets
Dublin, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The "Monkeypox Treatment Market: Focus on Therapeutics, Vaccines and Diagnostic Kits: Distribution by Type of Product, Drug Developers, Drug Candidates,...
Opportunities in the Artificial Intelligence in Drug Discovery Market Investor Report: Savings of $8.57 Billion Enabled by AI
January 04, 2023 06:48 ET
|
Research and Markets
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Investor Series: Opportunities in the Artificial Intelligence in Drug Discovery Market" report has been added to ResearchAndMarkets.com's offering. ...
Global SARM1 Inhibitors Market Report 2022 to 2040 - by Target Indications, Type of Molecules, Drug Developers, Drug Candidates and Key Geographies
December 16, 2022 07:23 ET
|
Research and Markets
Dublin, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The "SARM1 Inhibitors Market by Target Indications, Type of Molecules, Drug Developers, Drug Candidates and Key Geographies: Industry Trends and Global...
Immune Checkpoint Inhibitors Clinical Trial Analysis 2022: Wide Variety of Clinical and Preclinical Research Currently Ongoing Bodes Well for Growth
December 15, 2022 05:18 ET
|
Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical...
Artificial Intelligence In Drug Discovery Global Market Report 2022: Featuring Key Players IBM, Microsoft, Cloud Pharmaceuticals & Others
August 15, 2022 04:38 ET
|
Research and Markets
Dublin, Aug. 15, 2022 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022, By Technology, By Drug Type, By Therapeutic Type, By End-Users" report has...
Global Compound Management Market (2022 to 2030) - Rising Demand for Outsourcing Compound Management Services is Driving Growth
July 18, 2022 05:48 ET
|
Research and Markets
Dublin, July 18, 2022 (GLOBE NEWSWIRE) -- The "Global Compound Management Market Size, Share & Trends Analysis Report by Type (Products, Service), by Sample Type (Chemical Compounds, Bio...
Down Syndrome Drugs in Development, Worldwide, 2022 Update - Analysis by Stages, Target, MoA, RoA, Molecule Type, and Key Players
March 14, 2022 07:28 ET
|
Research and Markets
Dublin, March 14, 2022 (GLOBE NEWSWIRE) -- The "Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update" report has been added to...